Vor Biopharma Inc. (VOR)
NASDAQ: VOR
· Real-Time Price · USD
2.13
0.15 (7.58%)
At close: Aug 15, 2025, 3:59 PM
2.12
-0.24%
After-hours: Aug 15, 2025, 07:58 PM EDT
Vor Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.69M | 3.69M | 3.69M | 12.23M | 12.23M | 12.23M | 12.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 3.83M | 2.63M | 2.74M | 3.63M | 4.82M | 5.16M | 7M | 9.17M | 9.47M | 8.81M | 6.45M | 4.54M | 3.28M | 3.06M | 3.27M | 2.12M | 987K | 633K |
Gross Profit | -1.98M | -782K | -900K | 8.59M | 7.4M | 7.07M | 5.22M | -9.17M | -9.47M | -8.81M | -6.45M | -4.54M | -3.28M | -3.06M | -3.27M | -2.12M | -987K | -633K |
Operating Income | -367.4M | -122.15M | -121.19M | -118M | -124.8M | -127.94M | -126.04M | -122.64M | -111.42M | -101.04M | -93.42M | -87M | -81.5M | -78.09M | -69.02M | -66.38M | -59.56M | -49.22M |
Interest Income | 2.9M | 3.55M | 4.27M | 5.54M | 6.71M | 7.71M | 8.17M | 7.13M | 5.31M | 3.25M | 1.32M | 563K | 298K | 175K | 119K | 65K | 17K | 7K |
Pretax Income | -1.66B | -118.6M | -116.91M | -112.46M | -118.09M | -120.23M | -117.86M | -115.51M | -106.11M | -97.79M | -92.09M | -86.44M | -81.2M | -77.91M | -68.9M | -66.31M | -59.54M | -49.21M |
Net Income | -1.66B | -118.6M | -116.91M | -112.46M | -118.09M | -120.23M | -115.87M | -112.51M | -102.8M | -94.34M | -90.57M | -85.93M | -81.01M | -77.85M | -68.9M | -66.31M | -59.54M | -49.21M |
Selling & General & Admin | 32.03M | 25.56M | 26.03M | 26.4M | 27.42M | 29.38M | 30.83M | 32.16M | 31.67M | 29.86M | 28.87M | 26.82M | 25.27M | 24.22M | 21.49M | 20.21M | 18.18M | 14.83M |
Research & Development | 335.37M | 95.69M | 93.31M | 88.86M | 94.65M | 96.72M | 94.31M | 90.48M | 79.75M | 71.19M | 64.55M | 60.18M | 56.23M | 53.87M | 47.53M | 46.17M | 41.38M | 34.39M |
Other Expenses | n/a | n/a | n/a | 892K | 892K | 892K | 892K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 367.4M | 121.25M | 119.34M | 116.16M | 122.96M | 127M | 126.04M | 122.64M | 111.42M | 101.04M | 93.42M | 87M | 81.5M | 78.09M | 69.02M | 66.38M | 59.56M | 49.22M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -900K | -1.84M | -2.73M | -2.73M | -1.83M | -892K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 367.4M | 122.15M | 121.19M | 118M | 124.8M | 127.94M | 126.04M | 122.64M | 111.42M | 101.04M | 93.42M | 87M | 81.5M | 78.09M | 69.02M | 66.38M | 59.56M | 49.22M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -1.99M | -3M | -3.31M | -3.45M | -1.52M | -509K | -196K | -63K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 125.27M | 124.82M | 68.71M | 68.47M | 68.3M | 68.03M | 67.89M | 67.61M | 67.03M | 66.27M | 46.5M | 38.01M | 37.44M | 37.29M | 36.93M | 36.93M | 36.84M | 22.26M |
Shares Outstanding (Diluted) | 125.27M | 124.82M | 68.71M | 68.47M | 68.3M | 68.03M | 67.89M | 67.61M | 67.03M | 66.27M | 46.5M | 38.01M | 37.44M | 37.29M | 36.93M | 36.93M | 36.84M | 22.26M |
EPS (Basic) | -13.67 | -1.52 | -1.71 | -1.65 | -1.74 | -1.78 | -1.73 | -1.83 | -1.96 | -2.08 | -2.29 | -2.29 | -2.17 | -2.1 | -2.11 | -2.32 | -2.79 | -2.95 |
EPS (Diluted) | -13.67 | -1.52 | -1.71 | -1.65 | -1.74 | -1.78 | -1.73 | -1.83 | -1.96 | -2.08 | -2.29 | -2.29 | -2.17 | -2.1 | -2.11 | -2.32 | -2.79 | -2.95 |
EBITDA | -365.68M | -119.56M | -117.66M | -114.44M | -121.2M | -124.34M | -122.54M | -119.41M | -108.19M | -98.1M | -90.89M | -84.71M | -79.73M | -76.54M | -67.58M | -65.09M | -58.46M | -48.37M |
EBIT | -1.67B | -122.15M | -121.19M | -118M | -124.8M | -127.94M | -126.04M | -122.64M | -111.42M | -101.04M | -93.42M | -87M | -81.5M | -78.09M | -69.02M | -66.38M | -59.56M | -49.22M |
Depreciation & Amortization | 4.64M | 3.41M | 3.53M | 3.56M | 3.6M | 3.96M | 5.81M | 7.98M | 9.47M | 8.81M | 6.45M | 4.54M | 3.28M | 3.06M | 3.27M | 2.36M | 1.42M | 1.17M |